Click here to receive MS news via e-mail
Treatments involving stem cells have shown promising results in the battle against multiple sclerosis, but FDA approval still awaits.
There’s a lot of hype about stem cell therapy and how it can stop multiple sclerosis (MS) in its tracks.
But it’s taking a long time for stem cell therapy to make waves in the United States despite some success in other parts of the world.
The U.S. National Library of Medicine and the National Institutes of Health (NIH) are touting stem cell therapy. But it has yet to be approved by the Food and Drug Administration (FDA).
Two Americans stand out in the race to use stem cell therapy to treat people who have MS.
One is Dr. Richard Burt, chief of the division of medicine-immunotherapy and autoimmune diseases at Northwestern University. He’s been a stem cell therapy advocate for more than 30 years.
READ MORE
MS Views and News
Providing educational information, resources and services for those affected by MS
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews